manilatimes5d
Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma
Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCC. Amezalpat builds ...
Business Insider24d
Coherus Presents Final Phase 2 Clinical Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025
Jan. 22, 2025 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, NASDAQ: CHRS), today announced final data from its Phase 2 open label clinical trial evaluating casdozokitug (casdozo), a ...
Frontiers8d
Using Oncolytic Viruses in Cancer Immunity and Immunotherapy: Hepatocellular Carcinoma, Gastric Cancer, and Colorectal Cancer
Oncolytic viruses (OVs) are viruses that infect and kill cancer cells while sparing healthy tissue, making them a promising therapeutic option in cancer ...
Frontiers12d
Novel Therapeutic Approaches for Biliary Tract Cancer and Hepatocellular Carcinoma, Volume II
Hepatobiliary cancers, which include biliary tract cancer (BTC) and hepatocellular carcinoma (HCC), are among the most lethal ...
C&EN13d
Lactate-Fueled Theranostic Nanoplatforms for Enhanced MRI-Guided Ferroptosis Synergistic with Immunotherapy of Hepatocellular Carcinoma
China Clinical College of The Affiliated Central Hospital, School of Medcine, Lishui University, Lishui 323000, China Shanxi Bethune Hospital, Third Hospital of Shanxi Medical University, Shanxi ...
emjreviews.com1d
Clinical Complete Response a New Prognostic Marker in Liver Cancer
CLINICAL complete response (cCR) is a strong predictor of prognosis in patients with unresectable hepatocellular carcinoma ...
oncnursingnews3d
Amezalpat Receives FDA Fast Track Designation for Hepatocellular Carcinoma
Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.
emjreviews.com11d
New Model Predicts Hepatocellular Carcinoma Risk in Patients with Noncirrhotic Hepatitis B
New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.
Why thousands of young Britons are at risk from the aggressive form of cancer that hit TV royal expert Katie Nicholl - and that strikes people seemingly at random
Thousands of young and seemingly healthy Britons are at risk of a once-rare form of aggressive liver cancer because GPs are ...
gut.bmj7d
Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults
This document, on the diagnosis and treatment of patients with hepatocellular carcinoma (HCC), was commissioned by the British Society of Gastroenterology as part of a wider initiative to develop ...